333 W. SANTA CLARA STREET, SUITE 900, SAN JOSE, CA
Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter
Earnings Release
Ramtin Agah Appointed Executive Chairman of RenovoRx, Inc.
Announces $10 Million at Market Private Placement
Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
RenovoRx Enters $3.7M Capital on Demand Sales Agreement with JonesTrading
Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update
Amended Annual Report
Q1
FY 2025
Q3
Q2
FY 2024
Notice of Late Filing for Annual Report
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Initial Statement of Beneficial Ownership
Submission Upload
Correspondence